The product targets a significant commercial opportunity in the US market, with an estimated total addressable market of 6.2 million units, as per IQVIA data as of September 2025, as per Zydus Life’s statement.
The product targets a significant commercial opportunity in the US market, with an estimated total addressable market of 6.2 million units, as per IQVIA data as of September 2025, as per Zydus Life’s statement.